Capital Research Global Investors’s New Frontier Health Corporation Ordinary Shares NFH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-6,233,657
Closed -$71.4M 466
2021
Q4
$71.4M Sell
6,233,657
-1,328,406
-18% -$15M 0.02% 352
2021
Q3
$84.9M Sell
7,562,063
-3,051,358
-29% -$34M 0.02% 324
2021
Q2
$119M Sell
10,613,421
-1,559,965
-13% -$17.5M 0.03% 292
2021
Q1
$138M Hold
12,173,386
0.03% 278
2020
Q4
$105M Hold
12,173,386
0.03% 288
2020
Q3
$92.9M Hold
12,173,386
0.03% 275
2020
Q2
$101M Buy
12,173,386
+609,127
+5% +$4.94M 0.03% 261
2020
Q1
$95.4M Buy
11,564,259
+371,073
+3% +$3.37M 0.04% 237
2019
Q4
$111M Buy
+11,193,186
New +$114M 0.03% 254

Other funds holding NFH

Capital Research Global Investors's NFH Position: Q1 2022 in Review

Capital Research Global Investors sold out of New Frontier Health Corporation Ordinary Shares (NFH) in Q1 2022, closing a stake of 6,233,657 shares — an estimated $71.4M sold.

Capital Research Global Investors first reported a position in NFH in Q4 2019 and held it in 9 quarters. The position peaked at $138M in Q1 2021. 2 funds tracked by Wall St. Rank hold NFH as of Q1 2022.

  • Capital Research Global Investors reported no remaining New Frontier Health Corporation Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Capital Research Global Investors sold 6,233,657 New Frontier Health Corporation Ordinary Shares shares in Q1 2022, an estimated $71.4M.
  • Capital Research Global Investors first reported a position in New Frontier Health Corporation Ordinary Shares in Q4 2019 and held it in 9 quarters.
  • Capital Research Global Investors's New Frontier Health Corporation Ordinary Shares position peaked at $138M in Q1 2021.
  • 2 funds tracked by Wall St. Rank held New Frontier Health Corporation Ordinary Shares as of Q1 2022.

Based on Capital Research Global Investors's 13F filing for Q1 2022, filed 16 May 2022.